Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Invasive Breast Cancer × atezolizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 99 Carcinoma, Hepatocellular 57 Breast Neoplasms 41 Neoplasms 40 Small Cell Lung Carcinoma 39 Lung Neoplasms 34 Triple Negative Breast Neoplasms 32 Colorectal Neoplasms 31 Urinary Bladder Neoplasms 29 Melanoma 28 Neoplasm Metastasis 27 Carcinoma, Transitional Cell 26 Carcinoma, Renal Cell 21 Ovarian Neoplasms 18 Stomach Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 14 Head and Neck Neoplasms 14 Uterine Cervical Neoplasms 13 Liver Neoplasms 11 Recurrence 10 Prostatic Neoplasms 10 Lymphoma 9 Glioblastoma 9 Solid Tumors 8 Sarcoma 8 Pancreatic Neoplasms 8 Esophageal Neoplasms 8 Carcinoma, Merkel Cell 7 Solid Tumor 6 Rectal Neoplasms 6

Interventions

Trastuzumab 2 Surgical Procedures, Operative 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 pertuzumab 1 atezolizumab 1 Radiotherapy 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1 Indocyanine Green 1 Carboplatin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03595592 2024-03-06

APTneo

Fondazione Michelangelo

Phase 3 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡